CONMED Corporation to Announce Third Quarter 2021 Financial Results on October 27, 2021
October 04 2021 - 4:05PM
Business Wire
CONMED Corporation (NYSE: CNMD) today announced that it
will report financial results for the third quarter 2021 after the
market close on October 27, 2021. The Company’s management will
host a conference call at 4:30 p.m. ET that same day to discuss the
results.
To participate in the conference call, dial 1-844-889-7792
(domestic) or +1-661-378-9936 (international) and refer to the
passcode 6396565.
This conference call will also be webcast and can be accessed
from the “Investors” section of CONMED's website at www.conmed.com.
The webcast replay of the call will be available at the same site
approximately one hour after the end of the call.
A recording of the call will also be available from 7:30 p.m. ET
on Wednesday, October 27, 2021, until 7:30 p.m. ET on Wednesday,
November 3, 2021. To hear this recording, dial 1-855-859-2056
(domestic) or +1-404-537-3406 (international) and enter the
passcode 6396565.
About CONMED Corporation
CONMED is a medical technology company that provides surgical
devices and equipment for minimally invasive procedures. The
Company’s products are used by surgeons and physicians in a variety
of specialties, including orthopedics, general surgery, gynecology,
thoracic surgery, and gastroenterology. For more information, visit
www.conmed.com.
Forward-Looking Statements
This press release and the associated conference call may
contain forward-looking statements based on certain assumptions and
contingencies that involve risks and uncertainties, which could
cause actual results, performance, or trends to differ materially
from those expressed in the forward-looking statements herein or in
previous disclosures. For example, in addition to general industry
and economic conditions, factors that could cause actual results to
differ materially from those in the forward-looking statements may
include, but are not limited to, the risks posed to the Company’s
business, financial condition, and results of operations by the
COVID-19 global pandemic and the various government and other
responses to the pandemic, including deferral of surgeries,
reductions in hospital and ambulatory surgery center operating
volumes, disruption to potential supply chain reliability, as well
as the risk factors discussed in the Company's Annual Report on
Form 10-K for the full year ended December 31, 2020 and listed
under the heading Forward-Looking Statements in the Company’s most
recently filed Form 10-Q. Any and all forward-looking statements
are made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995 and relate to the
Company’s performance on a going-forward basis. The Company
believes that all forward-looking statements made by it have a
reasonable basis, but there can be no assurance that management’s
expectations, beliefs or projections as expressed in the
forward-looking statements will actually occur or prove to be
correct.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211004005002/en/
CONMED Corporation Todd W. Garner Chief
Financial Officer 727-214-2975
ToddGarner@conmed.com
CONMED (NYSE:CNMD)
Historical Stock Chart
From Sep 2024 to Oct 2024
CONMED (NYSE:CNMD)
Historical Stock Chart
From Oct 2023 to Oct 2024